{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:12:22Z","timestamp":1761988342118,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019748","name":"Johns Hopkins University Press","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcpo.2023.100462","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:04:45Z","timestamp":1701799485000},"page":"100462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0684-4263","authenticated-orcid":false,"given":"Sruthi","family":"Ranganathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Tuia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-8221","authenticated-orcid":false,"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcpo.2023.100462_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/d41573-023-00001-3","article-title":"2022 FDA approvals","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.jcpo.2023.100462_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.jcpo.2023.100462_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamaoto.2014.1570","article-title":"Unintended consequences of expensive cancer therapeutics\u2014the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture","volume":"140","author":"Fojo","year":"2014","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"issue":"9","key":"10.1016\/j.jcpo.2023.100462_bib4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jamaoncol.2016.0931","article-title":"An appraisal of clinically meaningful outcomes guidelines for oncology clinical trials","volume":"2","author":"Kumar","year":"2016","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.jcpo.2023.100462_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrclinonc.2017.27","article-title":"Drugs that lack single-agent activity: are they worth pursuing in combination","volume":"14","author":"Gyawali","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jcpo.2023.100462_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamainternmed.2019.0583","article-title":"An OVerview of Cancer Drugs Approved by the US Food and Drug Administration based on the surrogate end point of response rate","volume":"179","author":"Chen","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jcpo.2023.100462_bib7","unstructured":"ESMO. ESMO-MCBS Scorecards [Internet]. [cited 2023 Oct 5]. Available from: https:\/\/www.esmo.org\/guidelines\/esmo-mcbs\/esmo-mcbs-for-solid-tumours\/esmo-mcbs-scorecards."},{"issue":"1","key":"10.1016\/j.jcpo.2023.100462_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09383-w","article-title":"Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial","volume":"22","author":"Oda","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jcpo.2023.100462_bib9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jamaoncol.2015.6315","article-title":"Response rate as a regulatory end point in single-arm studies of advanced solid tumors","volume":"2","author":"Oxnard","year":"2016","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.jcpo.2023.100462_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2141.2009.08023.x","article-title":"Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma","volume":"148","author":"Sinha","year":"2010","journal-title":"Br. J. Haematol."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538323000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538323000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:07:53Z","timestamp":1761988073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538323000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":10,"alternative-id":["S2213538323000796"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2023.100462","relation":{},"ISSN":["2213-5383"],"issn-type":[{"type":"print","value":"2213-5383"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2023.100462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100462"}}